IS7559A - Spírósýklísk piperidín sem MCH1 mótlyf og notkun á þeim - Google Patents

Spírósýklísk piperidín sem MCH1 mótlyf og notkun á þeim

Info

Publication number: IS7559A
Authority: IS; Iceland
Prior art keywords: subject; compound; provides; pharmaceutically acceptable; pharmaceutical composition
Prior art date: 2002-07-03

Application number

IS7559A

Other languages

English (en)

Inventor

Marzabadi Mohammad

Jiang Yu

Lu Kai

Chen Chien-An

Deleon John

Wetzel John

Andersen Kim

Original Assignee

H. Lundbeck A/S

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-07-03

Filing date

2004-11-26

Publication date

2004-11-26

2004-11-26 Application filed by H. Lundbeck A/S filed Critical H. Lundbeck A/S

2004-11-26 Publication of IS7559A publication Critical patent/IS7559A/is

Links

239000005557 antagonist Substances 0.000 title abstract 2
101150104680 MCH1 gene Proteins 0.000 title 1
101100382379 Rattus norvegicus Cap1 gene Proteins 0.000 title 1
150000003053 piperidines Chemical class 0.000 title 1
150000001875 compounds Chemical class 0.000 abstract 6
239000003937 drug carrier Substances 0.000 abstract 3
239000008194 pharmaceutical composition Substances 0.000 abstract 3
208000019901 Anxiety disease Diseases 0.000 abstract 2
XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 abstract 2
230000036506 anxiety Effects 0.000 abstract 2
208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
230000002485 urinary effect Effects 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D221/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
- C07D221/02—Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
- C07D221/20—Spiro-condensed ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/26—Psychostimulants, e.g. nicotine, cocaine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/36—Opioid-abuse
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/10—Drugs for disorders of the endocrine system of the posterior pituitary hormones, e.g. oxytocin, ADH
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
- A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/02—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
- C07D491/10—Spiro-condensed systems

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Cardiology (AREA)
Urology & Nephrology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Hematology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Hospice & Palliative Care (AREA)
Addiction (AREA)
Emergency Medicine (AREA)
Orthopedic Medicine & Surgery (AREA)
Child & Adolescent Psychology (AREA)
Rheumatology (AREA)
Psychology (AREA)
Reproductive Health (AREA)
Toxicology (AREA)
Anesthesiology (AREA)

IS7559A 2002-07-03 2004-11-26 Spírósýklísk piperidín sem MCH1 mótlyf og notkun á þeim IS7559A (is)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US18914602A	2002-07-03	2002-07-03
PCT/US2003/021348 WO2004004714A1 (en)	2002-07-03	2003-07-03	Spirocyclic piperidines as mch1 antagonists and uses thereof

Publications (1)

Publication Number	Publication Date
IS7559A true IS7559A (is)	2004-11-26

Family

ID=30114021

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS7559A IS7559A (is)	2002-07-03	2004-11-26	Spírósýklísk piperidín sem MCH1 mótlyf og notkun á þeim

Country Status (21)

Country	Link
US (1)	US7335665B2 (is)
EP (1)	EP1531816B1 (is)
JP (1)	JP2006501188A (is)
KR (1)	KR20050047075A (is)
CN (1)	CN1668300A (is)
AT (1)	ATE421504T1 (is)
AU (1)	AU2003261133A1 (is)
BR (1)	BR0312256A (is)
CA (1)	CA2485375A1 (is)
DE (1)	DE60325973D1 (is)
EA (1)	EA007387B1 (is)
ES (1)	ES2318165T3 (is)
IL (1)	IL165906A0 (is)
IS (1)	IS7559A (is)
MX (1)	MXPA04012171A (is)
NO (1)	NO20050145L (is)
NZ (1)	NZ536844A (is)
PL (1)	PL373622A1 (is)
UA (1)	UA77814C2 (is)
WO (1)	WO2004004714A1 (is)
ZA (1)	ZA200409426B (is)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6374762B1 (en) *	1997-10-27	2002-04-23	Correct Craft, Inc.	Water sport towing apparatus
US7199135B2 (en)	2001-07-05	2007-04-03	H. Lundbeck A/S	Substituted alkyl amido piperidines
US7105544B2 (en)	2001-07-05	2006-09-12	Synaptic Pharmaceutical Corporation	Substituted alkyl amido piperidines
JP2006511500A (ja) *	2002-10-30	2006-04-06	メルク　エンド　カムパニー　インコーポレーテッド	γ−アミノアミド系のケモカイン受容体活性調節剤
US7727998B2 (en) *	2003-02-10	2010-06-01	Banyu Pharmaceutical Co., Ltd.	Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient
RU2007109794A (ru)	2004-08-19	2008-09-27	Вертекс Фармасьютикалз, Инкорпорейтед (Us)	Модуляторы мускариновых рецепторов
US7786141B2 (en)	2004-08-19	2010-08-31	Vertex Pharmaceuticals Incorporated	Dihydrospiroindene modulators of muscarinic receptors
WO2006058303A2 (en)	2004-11-29	2006-06-01	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
JP2009507800A (ja)	2005-09-09	2009-02-26	ユーロ−セルティークエス．エイ．	縮合およびスピロ環化合物ならびにその使用
AU2006330866A1 (en) *	2005-12-22	2007-07-05	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
WO2007098826A2 (en) *	2006-01-18	2007-09-07	Siena Biotech S.P.A.	Modulators of alpha7 nicotinic acetylcholine receptors and therapeutic uses thereof
RU2008137593A (ru) *	2006-02-22	2010-03-27	Вертекс Фармасьютикалз Инкорпорейтед (Us)	Модуляторы мускариновых рецепторов
RU2008137583A (ru) *	2006-02-22	2010-03-27	Вертекс Фармасьютикалз Инкорпорейшн (Us)	Спиропиперидины в качестве модуляторов мускариновых рецепторов
US7858790B2 (en) *	2006-06-29	2010-12-28	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
EP2051712A2 (en) *	2006-08-15	2009-04-29	Vertex Pharmceuticals Incorporated	Modulators of muscarinic receptors
AU2007284350A1 (en)	2006-08-18	2008-02-21	Vertex Pharmaceuticals Incorporated	Modulators of muscarinic receptors
WO2008038692A1 (en) *	2006-09-28	2008-04-03	Banyu Pharmaceutical Co., Ltd.	Diaryl ketimine derivative
CL2008000119A1 (es)	2007-01-16	2008-05-16	Wyeth Corp	Compuestos derivados de pirazol, antagonistas del receptor nicotinico de acetilcolina; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como demencia senil, alzheimer y esquizofrenia.
KR100816267B1 (ko) *	2007-07-18	2008-03-25	주식회사 코리아나화장품	천상초 추출물을 유효성분으로 함유하는 화장료 조성물
EP2207549A1 (en) *	2007-10-03	2010-07-21	Vertex Pharmceuticals Incorporated	Modulators of muscarinic receptors
CA2718723C (en) *	2008-03-19	2018-05-08	Aurimmed Pharma, Inc.	Novel compounds advantageous in the treatment of central nervous system diseases and disorders
US10793515B2 (en)	2008-03-19	2020-10-06	Aurimmed Pharma, Inc.	Compounds advantageous in the treatment of central nervous system diseases and disorders
US20210130285A1 (en)	2008-03-19	2021-05-06	Aurimmed Pharma, Inc.	Novel compounds advantageous in the treatment of central nervous system diseases and disorders
WO2011137024A1 (en) *	2010-04-26	2011-11-03	Merck Sharp & Dohme Corp.	Novel spiropiperidine prolylcarboxypeptidase inhibitors

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2006A (en) *		1841-03-16		Clamp for crimping leather
US5382583A (en) *	1989-04-22	1995-01-17	John Wyeth & Brother, Limited	Piperazine derivatives
WO1997045415A1 (en)	1996-05-28	1997-12-04	Rotta Research Laboratorium S.P.A.	Polyamide derivatives or ornithine, lysine and analogous substances with cck-b and gastrin-antagonistic activity
WO1998025604A1 (en)	1996-12-13	1998-06-18	Merck & Co., Inc.	Spiro-substituted azacycles as modulators of chemokine receptor activity
EP1299362A4 (en)	2000-07-05	2004-11-03	Synaptic Pharma Corp	SELECTIVE RECEPTOR ANTAGONISTS OF MELANINE CONCENTRATING HORMON-1 (MCH1) AND THEIR USE
WO2002002744A2 (en)	2000-07-05	2002-01-10	Synaptic Pharmaceutical Corporation	Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof
WO2002088089A1 (en) *	2001-04-19	2002-11-07	Banyu Pharmaceutical Co., Ltd.	Spiropiperidine derivatives, nociceptin receptor antagonists containing the same as the active ingredient and medicinal compositions
JP2004536104A (ja)	2001-07-05	2004-12-02	シナプティック・ファーマスーティカル・コーポレーション	Ｍｃｈ選択的アンタゴニストとしての置換されたアニリン−ピペリジン誘導体
US7727998B2 (en)	2003-02-10	2010-06-01	Banyu Pharmaceutical Co., Ltd.	Melanin-concentrating hormone receptor antagonists containing piperidine derivatives as the active ingredient

2003
- 2003-03-07 UA UA20041210497A patent/UA77814C2/uk unknown
- 2003-07-03 US US10/518,939 patent/US7335665B2/en not_active Expired - Fee Related
- 2003-07-03 NZ NZ536844A patent/NZ536844A/en unknown
- 2003-07-03 JP JP2004520024A patent/JP2006501188A/ja not_active Withdrawn
- 2003-07-03 MX MXPA04012171A patent/MXPA04012171A/es not_active Application Discontinuation
- 2003-07-03 ES ES03763351T patent/ES2318165T3/es not_active Expired - Lifetime
- 2003-07-03 EA EA200500156A patent/EA007387B1/ru not_active IP Right Cessation
- 2003-07-03 PL PL03373622A patent/PL373622A1/xx not_active Application Discontinuation
- 2003-07-03 AT AT03763351T patent/ATE421504T1/de not_active IP Right Cessation
- 2003-07-03 BR BR0312256-5A patent/BR0312256A/pt not_active IP Right Cessation
- 2003-07-03 CN CNA038158833A patent/CN1668300A/zh active Pending
- 2003-07-03 AU AU2003261133A patent/AU2003261133A1/en not_active Abandoned
- 2003-07-03 EP EP03763351A patent/EP1531816B1/en not_active Expired - Lifetime
- 2003-07-03 KR KR1020057000069A patent/KR20050047075A/ko not_active Withdrawn
- 2003-07-03 CA CA002485375A patent/CA2485375A1/en not_active Abandoned
- 2003-07-03 WO PCT/US2003/021348 patent/WO2004004714A1/en not_active Ceased
- 2003-07-03 DE DE60325973T patent/DE60325973D1/de not_active Expired - Fee Related
2004
- 2004-11-23 ZA ZA200409426A patent/ZA200409426B/en unknown
- 2004-11-26 IS IS7559A patent/IS7559A/is unknown
- 2004-12-21 IL IL16590604A patent/IL165906A0/xx unknown
2005
- 2005-01-11 NO NO20050145A patent/NO20050145L/no not_active Application Discontinuation

Also Published As

Publication number	Publication date
EP1531816A1 (en)	2005-05-25
JP2006501188A (ja)	2006-01-12
ZA200409426B (en)	2006-04-26
MXPA04012171A (es)	2005-02-25
ES2318165T3 (es)	2009-05-01
US20060173027A1 (en)	2006-08-03
BR0312256A (pt)	2005-04-26
WO2004004714A1 (en)	2004-01-15
NO20050145L (no)	2005-01-11
UA77814C2 (en)	2007-01-15
DE60325973D1 (de)	2009-03-12
NZ536844A (en)	2007-02-23
EA007387B1 (ru)	2006-10-27
CA2485375A1 (en)	2004-07-15
EP1531816B1 (en)	2009-01-21
KR20050047075A (ko)	2005-05-19
US7335665B2 (en)	2008-02-26
EA200500156A1 (ru)	2005-06-30
EP1531816A4 (en)	2005-12-28
AU2003261133A1 (en)	2004-01-23
CN1668300A (zh)	2005-09-14
PL373622A1 (en)	2005-09-05
ATE421504T1 (de)	2009-02-15
IL165906A0 (en)	2006-01-15

Publication	Publication Date	Title
IS7559A (is)	2004-11-26	Spírósýklísk piperidín sem MCH1 mótlyf og notkun á þeim
MXPA05006956A (es)	2005-10-26	Alquilamidopiperidinas sustituidas.
WO2002060392A3 (en)	2003-09-25	Use of gal3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
DE60231341D1 (de)	2009-04-09	Fluor- und sulfonylaminohaltige, 3,6-disubstituierptorantagonisten
MXPA02001306A (es)	2004-06-22	Composiciones farmaceuticas para el tratamiento de enfermedades del sistema nervioso central y otras enfermedades.
BR0210855A (pt)	2006-10-24	Método de fabricação de formulações de liberação prolongada
EP1194421A4 (en)	2002-09-11	SELECTIVE NPY (Y5) ANTAGONISTS
SE0100568D0 (sv)	2001-02-20	Compounds
ATE342264T1 (de)	2006-11-15	Indolderivate und deren verwendung als gnrh antagonisten
MXPA01008993A (es)	2004-11-10	Tratamiento de combinacion para depresion y ansiedad.
TW200631956A (en)	2006-09-16	Azabenzoxazoles for the treatment of CNS disorders
EA200501594A1 (ru)	2006-08-25	Замещенные производные азабициклогексана в качестве антагонистов мускаринового рецептора
IS8377A (is)	2006-03-27	Arýlindenópyridín og arýlindenópyrimidín og notkun þeirra sem mótlyf A2A viðtaka adenósíns
EA200500152A1 (ru)	2005-06-30	Вторичные аминоанилиновые пиперидины в качестве антагонистов мкг1 и их применение
UA85575C2 (en)	2009-02-10	4-aryl piperidines
YU60803A (sh)	2006-05-25	Upotreba antagonista gal3 receptora u lečenju depresije i/ili uznemirenosti i jedinjenja korisna u tim postupcima
WO2004093789A3 (en)	2005-02-24	Use of galr3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
WO2003043640A3 (en)	2004-03-04	Treatment of major depressive disorder using glucocorticoid receptor antagonists
SE0101692D0 (sv)	2001-05-14	Compounds
WO2006041635A8 (en)	2007-05-18	Arylthiobenzylpiperidine derivatives
WO2006041636A3 (en)	2006-06-15	Amino substituted aryloxybenzylpiperidine derivatives
WO2004034967A3 (en)	2004-07-15	2,4,6-triaminopyrimidines for the treatment of depression and/or anxiety
BR0210869A (pt)	2004-06-29	Composto, composição farmacêutica, processo de preparar uma composição farmacêutica, métodos de tratar um indivìduo que sofre de um distúrbio, de depressão e de ansiedade, obesidade, bexiga hiperativa e um distúrbio em um indivìduo, de reduzir a massa corporal de um indivìduo e de aliviar incontinência de urgência urinária e os sintomas de um distúrbio em um indivìduo
WO2006051413A8 (en)	2007-06-07	Azabenoxazoles for the treatment of cns disorders
AR060221A1 (es)	2008-06-04	Agentes serotonergicos para tratar disfuncion sexual